Immucell (ICCC) FCF Margin (2010 - 2026)
Immucell's FCF Margin came in at 4.07% for Q4 2025, up 6.64 percentage points from -2.57% a year earlier and up 36.33 percentage points from the prior quarter.
Powered by 
Analysis
Immucell (ICCC) FCF Margin (2010 - 2026) Analysis & Trends
For FY2025, Immucell's FCF Margin was 4.43%, up 4.84 percentage points from FY2024.
- FCF Margin carries a five-year change of +22.40 percentage points (FY2020 to FY2025).
- Going back by year, FCF Margin was -0.41% in FY2024 (+37.18 pp), -37.59% in FY2023 (-7.86 pp), -29.72% in FY2022 (-21.13 pp) and -8.60% in FY2021 (+9.37 pp).
- The five-year range for quarterly FCF Margin is -99.93% (Q1 2023) to 22.44% (Q2 2025).
- Year-over-year, FCF Margin increased in six of the last seven quarters, with an average year-over-year change of +24.10 percentage points.
- The fastest year-over-year change in FCF Margin over five years came in Q1 2024 (a gain of 104.73 percentage points), and the weakest in Q1 2023 (a drop of 97.11 percentage points).
- Business Quant data shows ICCC's FCF Margin at -32.26% (Q3 2025), 22.44% (Q2 2025) and 15.43% (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 28.96% |
| 10 | Immucell | 94.09 Mn | 70.73 Mn | 2.44 Mn | 31.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.80% |
| Mar 31, 2026 | 32.79% |
| Dec 31, 2025 | 4.07% |
| Sep 30, 2025 | -32.26% |
| Jun 30, 2025 | 22.44% |
| Mar 31, 2025 | 15.43% |
| Dec 31, 2024 | -2.57% |
| Sep 30, 2024 | -12.11% |
| Jun 30, 2024 | 8.61% |
| Mar 31, 2024 | 4.80% |
| Sep 30, 2023 | -19.33% |
| Jun 30, 2023 | -39.34% |
| Mar 31, 2023 | -99.93% |
| Dec 31, 2022 | -71.29% |
| Sep 30, 2022 | -41.54% |
| Jun 30, 2022 | -14.76% |
| Mar 31, 2022 | -2.82% |
| Dec 31, 2021 | -2.14% |
| Sep 30, 2021 | -8.09% |
| Jun 30, 2021 | -3.27% |
API Access
Immucell FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();